Reported Oct 28, 2026 · Ongoing · Updated Nov 2, 2026
Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA…
Hikma Pharmaceuticals USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Hikma Pharmaceuticals USA INC. · 1809 Wilson Rd · Columbus, OH · 43228-9579
Is this the product you have?
- Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only
- Mfd forHikma Pharmaceuticals USA Inc., Berkley Heights
- NJ 07922 USA byArab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12
- Lot codes and dates
Lot #: 3047Exp Date July 2027
- Amount recalled
- 2136 bottles
This recall covers 2 products
The agency filed one notice per product. You are reading one of them; the other one is below.
Where it was sold
- Nationwide
Why it was recalled
Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Hikma Pharmaceuticals USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.